Ningbo Menovo Pharmaceutical Co., Ltd (Shanghai: 603538) is an international pharmaceutical enterprise which is professional in researching, producing and marketing API, biopharmaceuticals and finished drug products.

1. MenovoSAPA 2017 Annual Conference

2. Ningbo Menovo Pharmaceutical
Co., Ltd (Shanghai: 603538) is
an international pharmaceutical
enterprise which is professional
in researching, producing and
marketing API,
biopharmaceuticals and finished
drug products.
Address: 12B-14F, Building 1,
Ningbo R&D Park, No.999, Yangfan
Rd, Hi-Tech Area, Ningbo China.

3. Since 2004, the company has engaged areas
including the technology of pharmaceutical
chemistry, bio-pharmaceutical and small
molecule in Anti-infection, cardiovascular,
central nervous system, respiratory system,
anti-tumor, digestive system, gerontology and
antiviral system.
Menovo has established and acquired a fully
integrated GMP manufacturing system which
will support the company to enter most
regulated markets. The high-quality
manufacturing force is composed of API section
and FDF section. In API section, the company
has four USFDA, EMA and PMDA certified API
factories. And in FDF section, the company has
one cGMP standard factory, one R&D center
focused on U.S. market and has one industrial
incubator under construction.
About Us

4. Structure

5. Offering
Global
Partnership
Your CMO Partner
• APIs, Intermediates, Finished Formulations
• Active Projects for the USA, Europe, and
Japan market
Experienced Regulatory and Marketing
Service Company
• Help international partners enter China
Market
Seeking Product Development Partners
• CRO, CDMOs, Marketing Companies
• Focus US and European Region
Actively focusing Investment Opportunities in
FDF & API Space, to form;
• Joint Venture
• Project Partnerships
• Acquisition
• Investment Funding
• Incubator
01
02
03
04

6. Opening Positions
• Vice President (API Business
Division)
• Vice President (FDF Business
Division)
• International BD General
Manager
• Dean of FDF R&D Center
• International RA Manager

7. The Institution of Innovative Medical Research in Ningbo
Gaoxin District is an industrial incubator that established by
Menovo Group and supported by Ningbo City Government.
The incubator will support the innovations and development
in biosimilar, small molecule generic drugs, and small
molecule proprietary drugs. The talents joined this incubator
will enjoy the benefit from the Ningbo Government Talent
Attraction Policy, which will reward qualified top talents 1
million RMB supporting fund per person and/or 5 million to
20 million RMB supporting fund per qualified team. For
breakthrough projects, the policy will reward the innovators
up to 100 million RMB supporting fund.
Besides the monetary support from the city government, and
for helping innovators chase their dreams, Menovo group will
provide the industrial and technical support including
manufacturing, regulation compliance, and
commercialization to all innovators. The flexible operation
mode with Menovo groups such as guaranteed acquisition
and technology invested as capital will maximize innovators'
benefit from their innovation.
The Institution
of Innovative
Medical
Research
(Incubator)

8. Contact
Doris Guan
Tel: +86-574-89079512
Cellphone: +86-13819869629
Email: guanyang@menovopharm.com
Website: www.menovopharm.com
Wechat: +86-13819869629
LinkedIn:
Ningbo Menovo Pharmaceutical Co.,
Ltd
Address: 12B-14F, Building 1, Ningbo
R&D Park, No.999, Yangfan Rd, Hi-
Tech Area, Ningbo China.